Joint Ease
Joint Ease, licence 80039079: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Cambridge Laboratories Joint Aid Plus, Joint Aid, Joint Aid Plus
- Licence holder
- Insight Enterprises Inc.
- NPN or DIN-HM
- 80039079
- Status
- Active licence
- Licence date
- 28 January 2013
- Revision date
- Not provided
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 66.67 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige Potency : 1000.0 GDU | 10.0 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 240000.0 FCC PU | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige Potency : 1000.0 GDU | 10.0 mg | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 240000.0 FCC PU | Not calculated |
Non-medicinal ingredients
Hypromellose, Silice, Phosphate de calcium, dibasique, Microcrystalline cellulose, Croscarmellose de sodium, Poly(éthylène glycol), Stéarate de magnésium, Acide stéarique, Hydroxypropylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 3.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in maintaining healthy cartilage. Helps to maintain healthy cartilage. A factor in maintaining joint health. Helps to maintain joint health. Helps the body to metabolize carbohydrates, fats and proteins. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. Helps to prevent vitamin C deficiency. Helps to prevent manganese deficiency. A factor in the maintenance of good health. Vitamin/mineral supplement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80039079
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.